Form D · Pharmaceuticals
Mobius Therapeutics LLC
St. Louis, MO · CIK 0001407296
Offering snapshot reported Oct 25, 2013 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 10, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 25, 2013 | Initial | $5,000,000 | No comparison | 19 | SEC filing |
| Nov 14, 2012 | Initial | $1,716,878 | No comparison | 5 | SEC filing |
| Dec 1, 2010 | Initial | $666,732 | No comparison | 11 | SEC filing |
| Jul 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-205277
Source: Form D, filed Oct 25, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Anderson | Executive |
| Ed Timm | Director, Executive |
| Edward J. Timm | Director, Executive |
| Dean Vandekamp | Director |
| Mark Wright | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4041 Forest Park Avenue
St. Louis, MO, 63108
St. Louis, MO, 63108